An Intestinal "transformers"-like Nanocarrier System for Enhancing the Oral Bioavailability of Poorly Water-Soluble Drugs

Er Yuan Chuang, Kun Ju Lin, Tring Yo Huang, Hsin Lung Chen, Yang Bao Miao, Po Yen Lin, Chiung Tong Chen, Jyuhn Huarng Juang, Hsing Wen Sung

研究成果: 雜誌貢獻文章

3 引文 (Scopus)

摘要

Increasing the intestinal dissolution of orally administered poorly water-soluble drugs that have poor oral bioavailability to a therapeutically effective level has long been an elusive goal. In this work, an approach that can greatly enhance the oral bioavailability of a poorly water-soluble drug such as curcumin (CUR) is developed, using a "Transformers"-like nanocarrier system (TLNS) that can self-emulsify the drug molecules in the intestinal lumen to form nanoemulsions. Owing to its known anti-inflammation activity, the use of CUR in treating pancreatitis is evaluated herein. Structural changes of the TLNS in the intestinal environment to form the CUR-laden nanoemulsions are confirmed in vitro. The therapeutic efficacy of this TLNS is evaluated in rats with experimentally induced acute pancreatitis (AP). Notably, the CUR-laden nanoemulsions that are obtained using the proposed TLNS can passively target intestinal M cells, in which they are transcytosed and then transported into the pancreatic tissues via the intestinal lymphatic system. The pancreases in rats that are treated with the TLNS yield approximately 12 times stronger CUR signals than their counterparts receiving free CUR, potentially improving the recovery of AP. These findings demonstrate that the proposed TLNS can markedly increase the intestinal drug dissolution, making oral delivery a favorable noninvasive means of administering poorly water-soluble drugs.
原文英語
頁(從 - 到)6389-6397
頁數9
期刊ACS Nano
12
發行號7
DOIs
出版狀態已發佈 - 七月 24 2018

指紋

bioavailability
Curcumin
transformers
drugs
Water
Rats
Dissolution
Pharmaceutical Preparations
water
rats
dissolving
Tissue
Recovery
pancreas
Molecules
lumens
lymphatic system
Biological Availability
delivery
recovery

ASJC Scopus subject areas

  • Materials Science(all)
  • Engineering(all)
  • Physics and Astronomy(all)

引用此文

An Intestinal "transformers"-like Nanocarrier System for Enhancing the Oral Bioavailability of Poorly Water-Soluble Drugs. / Chuang, Er Yuan; Lin, Kun Ju; Huang, Tring Yo; Chen, Hsin Lung; Miao, Yang Bao; Lin, Po Yen; Chen, Chiung Tong; Juang, Jyuhn Huarng; Sung, Hsing Wen.

於: ACS Nano, 卷 12, 編號 7, 24.07.2018, p. 6389-6397.

研究成果: 雜誌貢獻文章

Chuang, EY, Lin, KJ, Huang, TY, Chen, HL, Miao, YB, Lin, PY, Chen, CT, Juang, JH & Sung, HW 2018, 'An Intestinal "transformers"-like Nanocarrier System for Enhancing the Oral Bioavailability of Poorly Water-Soluble Drugs', ACS Nano, 卷 12, 編號 7, 頁 6389-6397. https://doi.org/10.1021/acsnano.8b00470
Chuang, Er Yuan ; Lin, Kun Ju ; Huang, Tring Yo ; Chen, Hsin Lung ; Miao, Yang Bao ; Lin, Po Yen ; Chen, Chiung Tong ; Juang, Jyuhn Huarng ; Sung, Hsing Wen. / An Intestinal "transformers"-like Nanocarrier System for Enhancing the Oral Bioavailability of Poorly Water-Soluble Drugs. 於: ACS Nano. 2018 ; 卷 12, 編號 7. 頁 6389-6397.
@article{07e2a15b15e149bdbaa173e0ef3df948,
title = "An Intestinal {"}transformers{"}-like Nanocarrier System for Enhancing the Oral Bioavailability of Poorly Water-Soluble Drugs",
abstract = "Increasing the intestinal dissolution of orally administered poorly water-soluble drugs that have poor oral bioavailability to a therapeutically effective level has long been an elusive goal. In this work, an approach that can greatly enhance the oral bioavailability of a poorly water-soluble drug such as curcumin (CUR) is developed, using a {"}Transformers{"}-like nanocarrier system (TLNS) that can self-emulsify the drug molecules in the intestinal lumen to form nanoemulsions. Owing to its known anti-inflammation activity, the use of CUR in treating pancreatitis is evaluated herein. Structural changes of the TLNS in the intestinal environment to form the CUR-laden nanoemulsions are confirmed in vitro. The therapeutic efficacy of this TLNS is evaluated in rats with experimentally induced acute pancreatitis (AP). Notably, the CUR-laden nanoemulsions that are obtained using the proposed TLNS can passively target intestinal M cells, in which they are transcytosed and then transported into the pancreatic tissues via the intestinal lymphatic system. The pancreases in rats that are treated with the TLNS yield approximately 12 times stronger CUR signals than their counterparts receiving free CUR, potentially improving the recovery of AP. These findings demonstrate that the proposed TLNS can markedly increase the intestinal drug dissolution, making oral delivery a favorable noninvasive means of administering poorly water-soluble drugs.",
keywords = "intestinal lymphatic transport, M cells, oral drug delivery, pancreatitis, poorly water-soluble drug",
author = "Chuang, {Er Yuan} and Lin, {Kun Ju} and Huang, {Tring Yo} and Chen, {Hsin Lung} and Miao, {Yang Bao} and Lin, {Po Yen} and Chen, {Chiung Tong} and Juang, {Jyuhn Huarng} and Sung, {Hsing Wen}",
year = "2018",
month = "7",
day = "24",
doi = "10.1021/acsnano.8b00470",
language = "English",
volume = "12",
pages = "6389--6397",
journal = "ACS Nano",
issn = "1936-0851",
publisher = "American Chemical Society",
number = "7",

}

TY - JOUR

T1 - An Intestinal "transformers"-like Nanocarrier System for Enhancing the Oral Bioavailability of Poorly Water-Soluble Drugs

AU - Chuang, Er Yuan

AU - Lin, Kun Ju

AU - Huang, Tring Yo

AU - Chen, Hsin Lung

AU - Miao, Yang Bao

AU - Lin, Po Yen

AU - Chen, Chiung Tong

AU - Juang, Jyuhn Huarng

AU - Sung, Hsing Wen

PY - 2018/7/24

Y1 - 2018/7/24

N2 - Increasing the intestinal dissolution of orally administered poorly water-soluble drugs that have poor oral bioavailability to a therapeutically effective level has long been an elusive goal. In this work, an approach that can greatly enhance the oral bioavailability of a poorly water-soluble drug such as curcumin (CUR) is developed, using a "Transformers"-like nanocarrier system (TLNS) that can self-emulsify the drug molecules in the intestinal lumen to form nanoemulsions. Owing to its known anti-inflammation activity, the use of CUR in treating pancreatitis is evaluated herein. Structural changes of the TLNS in the intestinal environment to form the CUR-laden nanoemulsions are confirmed in vitro. The therapeutic efficacy of this TLNS is evaluated in rats with experimentally induced acute pancreatitis (AP). Notably, the CUR-laden nanoemulsions that are obtained using the proposed TLNS can passively target intestinal M cells, in which they are transcytosed and then transported into the pancreatic tissues via the intestinal lymphatic system. The pancreases in rats that are treated with the TLNS yield approximately 12 times stronger CUR signals than their counterparts receiving free CUR, potentially improving the recovery of AP. These findings demonstrate that the proposed TLNS can markedly increase the intestinal drug dissolution, making oral delivery a favorable noninvasive means of administering poorly water-soluble drugs.

AB - Increasing the intestinal dissolution of orally administered poorly water-soluble drugs that have poor oral bioavailability to a therapeutically effective level has long been an elusive goal. In this work, an approach that can greatly enhance the oral bioavailability of a poorly water-soluble drug such as curcumin (CUR) is developed, using a "Transformers"-like nanocarrier system (TLNS) that can self-emulsify the drug molecules in the intestinal lumen to form nanoemulsions. Owing to its known anti-inflammation activity, the use of CUR in treating pancreatitis is evaluated herein. Structural changes of the TLNS in the intestinal environment to form the CUR-laden nanoemulsions are confirmed in vitro. The therapeutic efficacy of this TLNS is evaluated in rats with experimentally induced acute pancreatitis (AP). Notably, the CUR-laden nanoemulsions that are obtained using the proposed TLNS can passively target intestinal M cells, in which they are transcytosed and then transported into the pancreatic tissues via the intestinal lymphatic system. The pancreases in rats that are treated with the TLNS yield approximately 12 times stronger CUR signals than their counterparts receiving free CUR, potentially improving the recovery of AP. These findings demonstrate that the proposed TLNS can markedly increase the intestinal drug dissolution, making oral delivery a favorable noninvasive means of administering poorly water-soluble drugs.

KW - intestinal lymphatic transport

KW - M cells

KW - oral drug delivery

KW - pancreatitis

KW - poorly water-soluble drug

UR - http://www.scopus.com/inward/record.url?scp=85048054925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048054925&partnerID=8YFLogxK

U2 - 10.1021/acsnano.8b00470

DO - 10.1021/acsnano.8b00470

M3 - Article

AN - SCOPUS:85048054925

VL - 12

SP - 6389

EP - 6397

JO - ACS Nano

JF - ACS Nano

SN - 1936-0851

IS - 7

ER -